Literature DB >> 19025455

PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.

Dongsheng Yu1, Anxun Wang, Hongzhang Huang, Yiyang Chen.   

Abstract

AIMS: Previous studies revealed that drug-loaded poly(ethylene-glycol)-poly(gamma-benzyl-L-glutamate) (PEG-PBLG) nanoparticles exhibit favorable pharmacokinetic characteristics in the treatment of oral squamous cell carcinoma (OSCC). In this study, the characteristics and anticancer effect of herpes simplex virus thymidine kinase (HSV-TK)-loaded PEG-PBLG nanoparticles for OSCC were investigated. MATERIALS &
METHODS: HSV-TK-loaded PEG-PBLG nanoparticles were prepared and their morphology, DNA protection and gene-transfer efficiency were evaluated. Their anticancer effect in vitro and in vivo was determined. RESULTS & DISCUSSION: HSV-TK-loaded PEG-PBLG nanoparticles have a core-shell structure and DNA protection and higher gene-transfer efficiency. PEG-PBLG nanoparticle-mediated HSV-TK/ganciclovir (GCV) had a strong anticancer effect on Tca8113 cells in vitro and buccal carcinoma induced in golden hamsters.
CONCLUSION: PEG-PBLG nanoparticles may be a superior gene carrier in future clinical applications because of their DNA protection and higher gene-transfer efficiency. The HSV-TK/GCV suicide-gene system had significant antitumor effects on OSCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19025455     DOI: 10.2217/17435889.3.6.813

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  9 in total

1.  Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.

Authors:  Stacey L Demento; Weiguo Cui; Jason M Criscione; Eric Stern; Jacob Tulipan; Susan M Kaech; Tarek M Fahmy
Journal:  Biomaterials       Date:  2012-04-06       Impact factor: 12.479

2.  Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy.

Authors:  Pingchuan Ma; Jingmei Li; Yan Gao; Jieping Wu; Ke Men; Chunjie Li; Yi Men; Xingmei Duan
Journal:  Int J Nanomedicine       Date:  2022-07-04

Review 3.  Current trends of targeted therapy for oral squamous cell carcinoma.

Authors:  Hongjiao Li; Yao Zhang; Mengmeng Xu; Deqin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-02       Impact factor: 4.322

Review 4.  Gene transfer to plants by electroporation: methods and applications.

Authors:  Ibrahim Ilker Ozyigit
Journal:  Mol Biol Rep       Date:  2020-04-02       Impact factor: 2.316

Review 5.  The current state of head and neck cancer gene therapy.

Authors:  Sufi Mary Thomas; Jennifer Rubin Grandis
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

Review 6.  Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.

Authors:  Giovana Calixto; Jéssica Bernegossi; Bruno Fonseca-Santos; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2014-08-08

7.  Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.

Authors:  Antonella Mangraviti; Stephany Yi Tzeng; Kristen Lynn Kozielski; Yuan Wang; Yike Jin; David Gullotti; Mariangela Pedone; Nitsa Buaron; Ann Liu; David R Wilson; Sarah K Hansen; Fausto J Rodriguez; Guo-Dong Gao; Francesco DiMeco; Henry Brem; Alessandro Olivi; Betty Tyler; Jordan J Green
Journal:  ACS Nano       Date:  2015-02-10       Impact factor: 15.881

8.  The prophylactic effect of Acetobacter syzygii probiotic species against squamous cell carcinoma.

Authors:  Zahra Aghazadeh; Firoz Pouralibaba; Ahmad Yari Khosroushahi
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2017-12-13

Review 9.  Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer.

Authors:  Sangiliyandi Gurunathan; Min-Hee Kang; Muhammad Qasim; Jin-Hoi Kim
Journal:  Int J Mol Sci       Date:  2018-10-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.